Drug That Restricts Blood Supply to Prostate Tumors Delays Disease Progression, Johns Hopkins University, Roswell Park Cancer Institute And Duke University Study

ScienceDaily (June 8, 2010) — A blood vessel-blocking drug called tasquinimod slowed the rate of disease progression in a clinical trial of 200 prostate cancer patients, according to experts at Johns Hopkins, Roswell Park Cancer Institute and Duke University.